Atlas Trials

Entasis Therapeutics

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Entasis Therapeutics

RecordFirmDate
Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex (NCT03894046)Entasis Therapeutics2019-09-05
Study to Determine the Excretion and Metabolism of 14C-ETX2514 Administered Intravenously in Healthy Male Subjects (NCT04018950)Entasis Therapeutics2019-06-21
Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers (NCT03985410)Entasis Therapeutics2019-05-23
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK, the Measure of How the Human Body Processes a Substance) of ETX0282 When Administered Orally to Healthy Participants (NCT03491748)Entasis Therapeutics2018-03-16
Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections (NCT03445195)Entasis Therapeutics2018-01-17
Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects (NCT03310463)Entasis Therapeutics2017-10-03
Study to Determine and Compare Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam in Healthy Subjects (NCT03303924)Entasis Therapeutics2017-08-21
Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous ETX2514 Administered in Healthy Subjects (NCT02971423)Entasis Therapeutics2016-10-01
AZD0914 Phase 1 ADME Study in Healthy Volunteers (NCT02298920)Entasis Therapeutics2015-01-01

Track Entasis Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.